Detroit-based Henry Ford Innovations, part of Detroit-based Henry Ford Health System, is working with Semita, a healthcare software company also headquartered in the Motor City, to market a software application for specialty pharmacies worldwide.
The application, called DromosPTM, streamlines clinical activities for managing patients’ medication therapy. HFI says it’s the first-of-its kind application with capability to meet the needs of specialty pharmacists, providers, and manufacturers.
The agreement with Semita, a cloud-based software company, is the latest in a series of licensing agreements made by HFI to develop and commercialize its intellectual assets. Since its inception in 2011, HFI has signed 30 licensing agreements, representing $350 million in future revenue.
Semita is led by Detroit-based entrepreneur Paul Toenjes, who has more than 30 years of experience in software development, health care, and corporate leadership and business development. He also owns five patents in health care.
“We’re excited about the functionality that DromosPTM brings to the specialty pharmacy industry,” says Joseph Jankowski, senior advisor to HFI. “We believe Paul is the right fit for this opportunity, given his proven track record and entrepreneurial spirit.”
Toenjes called DromosPTM “the most robust technology today” in the specialty pharmacy industry.
Toenjes says, “DromosPTM fills a gap in this rapidly growing industry by providing a highly flexible and configurable platform that adapts to the way individual specialty pharmacists operate.”
DromosPTM manages the prior authorization process for medications, simplifies processes for delivering and refilling medications, and eliminates duplication and emphasizes best practices.
It also assists patients with finding financial assistance for their medication, enhances reporting and monitoring capabilities and advances configurable workflows to make quick, easy process changes due to evolving specialty pharmacy requirements.
Specialty pharmacies focus on high-cost, high-touch medication therapy for patients with complex and chronic diseases including dispensing, distribution, reimbursement, and case management. Some of these diseases include cancer, hepatitis C, HIV/AIDS, immune disorders, infertility, multiple sclerosis, and rheumatoid arthritis.
According to published reports, specialty pharmacy is estimated to be 50 percent of the total pharmaceutical costs by 2022. Currently, more than 60 percent of all new drugs under development are considered specialty medications.
DromosPTM is the brainchild of a team of specialty pharmacists at Pharmacy Advantage, the specialty pharmacy at Henry Ford Health System. They elected to build their own software application after concluding that existing products at the time didn’t meet the unique needs of specialty pharmacy management.
“DromosPTM is our vision of what a true specialty pharmacy patient therapy management software system should be,” says Jonathan Van Lare, director of Clinical and Specialty Pharmacy Services at Pharmacy Advantage. “It’s a software application built by clinical pharmacists for clinical pharmacists.”
The application is being demonstrated this week at the National Association of Specialty Pharmacy’s annual meeting and expo in Washington, D.C.